LY262691
LY262691 is a selective cholecystokinin B (CCKB) receptor antagonist. It has been shown to reduce the firing rate of dopaminergic neurons in the midbrain, making it a useful research tool for investigating the role of CCK in dopamine-related pathways in both in vitro and in vivo studies.
Product Specifications
CAS Number
138932-35-1
Field of Research
Pharmacology & Drug Discovery
Smiles
C (NC1=CC=C (Br) C=C1) (=O) N2[C@H] ([C@@H] (C (=O) N2) C3=CC=CC=C3) C4=CC=CC=C4
Molecular Formula
C22H18BrN3O2
Molecular Weight
436.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FCGR3A35-R-25 25 µg
Recombinant (HEK) Human FcGR3a/CD16a Protein (48-321aa, 176Phe, >95%, his-tag, ~45 kda, low endotoxins)
Sign In for Pricing
View Details 
12-8455-50 50 µg
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-F6) Biotin
Sign In for Pricing
View Details